nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—DCLK3—blood plasma—abdominal aortic aneurysm	0.026	0.069	CbGeAlD
Ruxolitinib—CAMK1—blood plasma—abdominal aortic aneurysm	0.0214	0.0568	CbGeAlD
Ruxolitinib—MARK2—blood plasma—abdominal aortic aneurysm	0.0208	0.0551	CbGeAlD
Ruxolitinib—BMPR2—artery—abdominal aortic aneurysm	0.0196	0.052	CbGeAlD
Ruxolitinib—ROCK1—blood plasma—abdominal aortic aneurysm	0.0151	0.0401	CbGeAlD
Ruxolitinib—PRKG2—kidney—abdominal aortic aneurysm	0.0138	0.0368	CbGeAlD
Ruxolitinib—MAP3K2—blood plasma—abdominal aortic aneurysm	0.0119	0.0317	CbGeAlD
Ruxolitinib—JAK2—blood plasma—abdominal aortic aneurysm	0.0106	0.028	CbGeAlD
Ruxolitinib—JAK3—connective tissue—abdominal aortic aneurysm	0.0094	0.025	CbGeAlD
Ruxolitinib—JAK1—connective tissue—abdominal aortic aneurysm	0.00934	0.0248	CbGeAlD
Ruxolitinib—TAOK3—blood plasma—abdominal aortic aneurysm	0.00927	0.0246	CbGeAlD
Ruxolitinib—HIPK2—connective tissue—abdominal aortic aneurysm	0.00872	0.0232	CbGeAlD
Ruxolitinib—ROCK1—connective tissue—abdominal aortic aneurysm	0.00804	0.0214	CbGeAlD
Ruxolitinib—JAK1—kidney—abdominal aortic aneurysm	0.00795	0.0211	CbGeAlD
Ruxolitinib—BMPR2—connective tissue—abdominal aortic aneurysm	0.00781	0.0207	CbGeAlD
Ruxolitinib—CAMK1—spinal cord—abdominal aortic aneurysm	0.00755	0.02	CbGeAlD
Ruxolitinib—HIPK2—kidney—abdominal aortic aneurysm	0.00742	0.0197	CbGeAlD
Ruxolitinib—BMP2K—connective tissue—abdominal aortic aneurysm	0.00699	0.0186	CbGeAlD
Ruxolitinib—ROCK1—kidney—abdominal aortic aneurysm	0.00685	0.0182	CbGeAlD
Ruxolitinib—DYRK1A—kidney—abdominal aortic aneurysm	0.00668	0.0177	CbGeAlD
Ruxolitinib—BMPR2—kidney—abdominal aortic aneurysm	0.00665	0.0177	CbGeAlD
Ruxolitinib—MAP3K2—connective tissue—abdominal aortic aneurysm	0.00635	0.0169	CbGeAlD
Ruxolitinib—JAK1—spinal cord—abdominal aortic aneurysm	0.00619	0.0164	CbGeAlD
Ruxolitinib—DCLK1—spinal cord—abdominal aortic aneurysm	0.00619	0.0164	CbGeAlD
Ruxolitinib—TYK2—connective tissue—abdominal aortic aneurysm	0.00618	0.0164	CbGeAlD
Ruxolitinib—MKNK2—connective tissue—abdominal aortic aneurysm	0.0061	0.0162	CbGeAlD
Ruxolitinib—RET—connective tissue—abdominal aortic aneurysm	0.00594	0.0158	CbGeAlD
Ruxolitinib—DAPK2—spinal cord—abdominal aortic aneurysm	0.00591	0.0157	CbGeAlD
Ruxolitinib—LRRK2—kidney—abdominal aortic aneurysm	0.0059	0.0157	CbGeAlD
Ruxolitinib—HIPK2—spinal cord—abdominal aortic aneurysm	0.00578	0.0154	CbGeAlD
Ruxolitinib—JAK2—connective tissue—abdominal aortic aneurysm	0.00562	0.0149	CbGeAlD
Ruxolitinib—DAPK3—spinal cord—abdominal aortic aneurysm	0.00555	0.0147	CbGeAlD
Ruxolitinib—TYK2—kidney—abdominal aortic aneurysm	0.00526	0.014	CbGeAlD
Ruxolitinib—RET—kidney—abdominal aortic aneurysm	0.00506	0.0134	CbGeAlD
Ruxolitinib—TAOK3—connective tissue—abdominal aortic aneurysm	0.00494	0.0131	CbGeAlD
Ruxolitinib—JAK2—kidney—abdominal aortic aneurysm	0.00478	0.0127	CbGeAlD
Ruxolitinib—CAMK2G—spinal cord—abdominal aortic aneurysm	0.00464	0.0123	CbGeAlD
Ruxolitinib—BMP2K—spinal cord—abdominal aortic aneurysm	0.00464	0.0123	CbGeAlD
Ruxolitinib—LRRK2—spinal cord—abdominal aortic aneurysm	0.00459	0.0122	CbGeAlD
Ruxolitinib—TAOK3—kidney—abdominal aortic aneurysm	0.0042	0.0112	CbGeAlD
Ruxolitinib—MAP3K7—spinal cord—abdominal aortic aneurysm	0.00417	0.0111	CbGeAlD
Ruxolitinib—TYK2—spinal cord—abdominal aortic aneurysm	0.00409	0.0109	CbGeAlD
Ruxolitinib—MKNK2—spinal cord—abdominal aortic aneurysm	0.00404	0.0107	CbGeAlD
Ruxolitinib—RET—spinal cord—abdominal aortic aneurysm	0.00394	0.0105	CbGeAlD
Ruxolitinib—JAK2—spinal cord—abdominal aortic aneurysm	0.00372	0.00989	CbGeAlD
Ruxolitinib—MAP3K3—spinal cord—abdominal aortic aneurysm	0.00359	0.00953	CbGeAlD
Ruxolitinib—TAOK3—spinal cord—abdominal aortic aneurysm	0.00327	0.00869	CbGeAlD
Ruxolitinib—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00282	0.00748	CbGeAlD
Ruxolitinib—CYP3A4—kidney—abdominal aortic aneurysm	0.00128	0.00339	CbGeAlD
Ruxolitinib—MAP3K7—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.00033	0.00053	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.000326	0.000524	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000324	0.00052	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—NOS2—abdominal aortic aneurysm	0.00032	0.000514	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.00032	0.000513	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—NCF1—abdominal aortic aneurysm	0.000317	0.000509	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000314	0.000504	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000314	0.000504	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—LDLR—abdominal aortic aneurysm	0.000313	0.000502	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by SCF-KIT—MMP9—abdominal aortic aneurysm	0.000313	0.000502	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—NOS2—abdominal aortic aneurysm	0.000312	0.0005	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000311	0.000499	CbGpPWpGaD
Ruxolitinib—JAK2—Toll-Like Receptors Cascades—NFKB1—abdominal aortic aneurysm	0.00031	0.000497	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000307	0.000492	CbGpPWpGaD
Ruxolitinib—MAP3K7—B Cell Activation—NFKB1—abdominal aortic aneurysm	0.000306	0.00049	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000305	0.00049	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—LRP1—abdominal aortic aneurysm	0.000305	0.000489	CbGpPWpGaD
Ruxolitinib—JAK2—BDNF signaling pathway—NFKB1—abdominal aortic aneurysm	0.000304	0.000488	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000302	0.000484	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000302	0.000484	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—SERPINE1—abdominal aortic aneurysm	0.000298	0.000479	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000297	0.000477	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—AAAS—abdominal aortic aneurysm	0.000295	0.000474	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—AGT—abdominal aortic aneurysm	0.000294	0.000471	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—NCF1—abdominal aortic aneurysm	0.000293	0.00047	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000289	0.000464	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000289	0.000464	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000289	0.000463	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—APOE—abdominal aortic aneurysm	0.000288	0.000462	CbGpPWpGaD
Ruxolitinib—JAK1—Axon guidance—MMP9—abdominal aortic aneurysm	0.000288	0.000461	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—AAAS—abdominal aortic aneurysm	0.000287	0.00046	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000285	0.000457	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000284	0.000456	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000283	0.000454	CbGpPWpGaD
Ruxolitinib—ROCK1—Axon guidance—MMP9—abdominal aortic aneurysm	0.000283	0.000454	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000282	0.000453	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—MMP2—abdominal aortic aneurysm	0.000282	0.000453	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.000282	0.000453	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000279	0.000447	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—AAAS—abdominal aortic aneurysm	0.000278	0.000446	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000274	0.00044	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000273	0.000438	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000272	0.000436	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000271	0.000434	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00027	0.000433	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—SERPINE1—abdominal aortic aneurysm	0.00027	0.000433	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000268	0.000431	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000266	0.000427	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000266	0.000427	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—AAAS—abdominal aortic aneurysm	0.000265	0.000425	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000263	0.000421	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—PTGS2—abdominal aortic aneurysm	0.000261	0.000418	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—SELL—abdominal aortic aneurysm	0.00026	0.000417	CbGpPWpGaD
Ruxolitinib—JAK2—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.000258	0.000414	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000256	0.000411	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000255	0.000409	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000251	0.000403	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000248	0.000398	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000247	0.000396	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000246	0.000394	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000244	0.000392	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000243	0.00039	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—NCF1—abdominal aortic aneurysm	0.000241	0.000387	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000241	0.000386	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000239	0.000383	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000238	0.000382	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000238	0.000382	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000236	0.000379	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—PTGS2—abdominal aortic aneurysm	0.000236	0.000378	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—NCF1—abdominal aortic aneurysm	0.000234	0.000376	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—PTGS2—abdominal aortic aneurysm	0.000232	0.000372	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000232	0.000372	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—LRP1—abdominal aortic aneurysm	0.000231	0.000371	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—LDLR—abdominal aortic aneurysm	0.000231	0.000371	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000229	0.000367	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000228	0.000366	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—NCF1—abdominal aortic aneurysm	0.000227	0.000364	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000227	0.000364	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000224	0.000359	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—APOE—abdominal aortic aneurysm	0.000223	0.000358	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000222	0.000357	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000222	0.000356	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00022	0.000353	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000219	0.000352	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—AAAS—abdominal aortic aneurysm	0.000217	0.000349	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NCF1—abdominal aortic aneurysm	0.000216	0.000347	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000216	0.000346	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000216	0.000346	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—MMP2—abdominal aortic aneurysm	0.000214	0.000343	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000214	0.000343	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000212	0.000341	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—MMP9—abdominal aortic aneurysm	0.000212	0.00034	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000209	0.000335	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—NOS2—abdominal aortic aneurysm	0.000208	0.000334	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000207	0.000332	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000206	0.00033	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000206	0.00033	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000205	0.000329	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000205	0.000329	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000203	0.000326	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000202	0.000325	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000202	0.000324	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000202	0.000324	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000202	0.000323	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000202	0.000323	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—AAAS—abdominal aortic aneurysm	0.000201	0.000322	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.0002	0.00032	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.0002	0.00032	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—PTGS2—abdominal aortic aneurysm	0.000197	0.000317	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000196	0.000315	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000194	0.000311	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000193	0.000309	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000191	0.000307	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000189	0.000303	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000188	0.000301	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000183	0.000294	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000179	0.000288	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000179	0.000287	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—NCF1—abdominal aortic aneurysm	0.000177	0.000285	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000176	0.000282	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—SERPINE1—abdominal aortic aneurysm	0.000175	0.000281	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—LDLR—abdominal aortic aneurysm	0.000175	0.000281	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—NOS2—abdominal aortic aneurysm	0.000175	0.00028	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000172	0.000275	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000171	0.000274	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00017	0.000273	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000168	0.00027	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000167	0.000267	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000165	0.000264	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NCF1—abdominal aortic aneurysm	0.000164	0.000263	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—APOE—abdominal aortic aneurysm	0.000162	0.00026	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000162	0.00026	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000162	0.00026	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000162	0.00026	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000162	0.000259	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—MMP9—abdominal aortic aneurysm	0.000161	0.000258	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00016	0.000257	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00016	0.000256	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000159	0.000255	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000158	0.000254	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000157	0.000252	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000156	0.000251	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000156	0.00025	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000156	0.00025	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—PTGS2—abdominal aortic aneurysm	0.000153	0.000245	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000153	0.000245	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000151	0.000243	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000151	0.000243	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000151	0.000243	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—NOS2—abdominal aortic aneurysm	0.000151	0.000242	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.00015	0.00024	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000147	0.000236	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000147	0.000235	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000147	0.000235	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000145	0.000232	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000145	0.000232	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000144	0.000232	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—NFKB1—abdominal aortic aneurysm	0.000144	0.000231	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000143	0.00023	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000139	0.000223	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000136	0.000219	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000135	0.000216	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000132	0.000212	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000132	0.000212	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—NFKB1—abdominal aortic aneurysm	0.000132	0.000211	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000131	0.000211	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—NFKB1—abdominal aortic aneurysm	0.000129	0.000206	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000128	0.000206	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—SERPINE1—abdominal aortic aneurysm	0.000127	0.000204	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000125	0.000201	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000123	0.000198	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000123	0.000197	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000123	0.000197	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000122	0.000195	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—NFKB1—abdominal aortic aneurysm	0.000121	0.000195	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000121	0.000194	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—APOE—abdominal aortic aneurysm	0.00012	0.000192	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000119	0.000191	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000118	0.000189	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000116	0.000186	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000115	0.000184	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000115	0.000184	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000114	0.000183	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000114	0.000182	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000114	0.000182	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000112	0.000179	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000112	0.000179	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NOS2—abdominal aortic aneurysm	0.000112	0.000179	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—PTGS2—abdominal aortic aneurysm	0.000111	0.000178	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000111	0.000178	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00011	0.000176	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000108	0.000174	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000105	0.000169	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—NFKB1—abdominal aortic aneurysm	0.000104	0.000167	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000104	0.000166	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.0001	0.000161	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	9.54e-05	0.000153	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MMP9—abdominal aortic aneurysm	9.4e-05	0.000151	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—SERPINE1—abdominal aortic aneurysm	9.39e-05	0.000151	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	9.38e-05	0.000151	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NFKB1—abdominal aortic aneurysm	9.3e-05	0.000149	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	9.21e-05	0.000148	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—APOE—abdominal aortic aneurysm	9.07e-05	0.000145	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	9.04e-05	0.000145	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	8.91e-05	0.000143	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—AGT—abdominal aortic aneurysm	8.81e-05	0.000141	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	8.76e-05	0.000141	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—APOE—abdominal aortic aneurysm	8.63e-05	0.000138	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—AGT—abdominal aortic aneurysm	8.55e-05	0.000137	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS2—abdominal aortic aneurysm	8.45e-05	0.000136	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—APOE—abdominal aortic aneurysm	8.38e-05	0.000134	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—AGT—abdominal aortic aneurysm	8.3e-05	0.000133	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP3—abdominal aortic aneurysm	8.21e-05	0.000132	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PTGS2—abdominal aortic aneurysm	8.2e-05	0.000132	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—APOE—abdominal aortic aneurysm	8.13e-05	0.00013	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—NFKB1—abdominal aortic aneurysm	7.94e-05	0.000127	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.93e-05	0.000127	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NFKB1—abdominal aortic aneurysm	7.85e-05	0.000126	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—NFKB1—abdominal aortic aneurysm	7.71e-05	0.000124	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—NFKB1—abdominal aortic aneurysm	7.48e-05	0.00012	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	7.26e-05	0.000116	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—SERPINE1—abdominal aortic aneurysm	7.12e-05	0.000114	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCL2—abdominal aortic aneurysm	7.04e-05	0.000113	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCL2—abdominal aortic aneurysm	6.83e-05	0.00011	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.82e-05	0.000109	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	6.77e-05	0.000109	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.75e-05	0.000108	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.71e-05	0.000108	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.64e-05	0.000106	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	6.58e-05	0.000105	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AGT—abdominal aortic aneurysm	6.48e-05	0.000104	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	6.38e-05	0.000102	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—APOE—abdominal aortic aneurysm	6.35e-05	0.000102	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTGS2—abdominal aortic aneurysm	6.21e-05	9.97e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—NFKB1—abdominal aortic aneurysm	5.84e-05	9.37e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.34e-05	8.56e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.19e-05	8.32e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.13e-05	8.23e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.04e-05	8.08e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.98e-05	7.99e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.98e-05	7.99e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MMP9—abdominal aortic aneurysm	4.89e-05	7.84e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.83e-05	7.75e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	4.75e-05	7.62e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	4.15e-05	6.65e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.82e-05	6.12e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.78e-05	6.06e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	2.19e-05	3.51e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	2.15e-05	3.44e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	1.47e-05	2.36e-05	CbGpPWpGaD
